Lugen SCI
Lugen R&D Service
- Gene SynthesisÀ¯ÀüÀÚ ÇÕ¼º
- Customized Cloning ServiceÄ¿½ºÅÒ Å¬·Î´× Á¦ÀÛ ¼ºñ½º
- Protein Purification´Ü¹éÁúÁ¤Á¦
- Custom Peptide SynthesisÄ¿½ºÅÒ ÆéŸÀ̵å ÇÕ¼º
- Plasmid DNA Prep ServiceºÐÀÚ »ý¹°ÇÐ ¼ºñ½º
- Lentivirus service·»Æ¼¹ÙÀÌ·¯½ºÁ¦ÀÛ
- Stable Cell Line½ºÅ×ºí ¼¿¶óÀÎ Á¦ÀÛ
- OA-EDSS ServiceÅðÇ༺ °üÀýÀç»ý À¯È¿¹°Áú ½ºÅ©¸®´× ¼ºñ½º
Lentivirus Packaging Service
¼ºñ½º °³¿ä
(ÁÖ)·çÁ¨¿¡½º¾¾¾ÆÀ̸¸ÀÇ °íÀ¯ ÇüÁúÀüȯ ±â¼úÀ» ÀÌ¿ëÇÑ ·»Æ¼¹ÙÀÌ·¯½º »ý»ê ½Ã½ºÅÛÀÔ´Ï´Ù. ·»Æ¼¹ÙÀÌ·¯½º º¤ÅÍ´Â ´Ù¾çÇÑ ºÐ¿ ¼¼Æ÷»Ó¸¸ ¾Æ´Ï¶ó ºÐ¿ÇÏÁö ¾Ê´Â ¼¼Æ÷¿¡µµ À¯ÀüÀÚ¸¦ ¿µ±¸ÀûÀ¸·Î µµÀÔÇÒ ¼ö ÀÖ´Â ÇüÁúÀüȯ ½Ã½ºÅÛÀ¸·Î ÇöÀç ÇüÁúÀüȯ ÀÀ¿ëºÐ¾ß¿¡¼ °¡Àå ¸¹ÀÌ ÀÌ¿ëµÇ´Â ±â¹ýÀÔ´Ï´Ù.
·»Æ¼¹ÙÀÌ·¯½º º¤ÅÍ µðÀÚÀÎ ¹× Ŭ·Î´×¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ´Â ¿¬±¸ÀÚ, ³·Àº ¿ª°¡ÀÇ ·»Æ¼¹ÙÀÌ·¯½º »ý»êÀ¸·Î °í¹Î ÁßÀÎ ¿¬±¸ÀÚ, ±×¸®°í ·»Æ¼¹ÙÀÌ·¯½º »ý»ê ¹× ½Ã¼³±¸ºñ¿¡ ½Ã°£Àû °æÁ¦Àû ¾î·Á¿òÀ» °Þ°í ÀÖ´Â ¿¬±¸Àںе鿡°Ô º» ¼ºñ½º¸¦ Ãßõ µå¸³´Ï´Ù.
¼ºñ½º Á¾·ù
- cDNA ¹ßÇö ·»Æ¼¹ÙÀÌ·¯½º
- Knock-down (KD) ·»Æ¼¹ÙÀÌ·¯½º
- Knock-out (KO, CRISPR/Cas9) ·»Æ¼¹ÙÀÌ·¯½º
- miRNA ¹ßÇö ·»Æ¼¹ÙÀÌ·¯½º
- Dox À¯µµ¹ßÇö (TetO inducible system) ·»Æ¼¹ÙÀÌ·¯½º
Ư¡ ¹× ÀåÁ¡
- Lentiviral transfer vector Ŭ·Î´×ºÎÅÍ ¹ÙÀÌ·¯½º »ý»ê±îÁö (Lentiviral transfer vector ¹«»óÁ¦°ø, cDNA Ŭ·Ð ±¸ÀÔºñ ¶Ç´Â À¯ÀüÀÚ ÇÕ¼ººñ º°µµ)
- ´Ù¾çÇÑ Cancer cell°ú Primary cell¿¡¼ ¾ÈÁ¤ÀûÀ¸·Î cDNA (KI), shRNA (KD), gRNA (KO), miRNA ¹ßÇöÀ¯µµ
- 2 & 3 Generation VSV-G pseudo-envelop type lentivirus packaging ¸ðµÎ °¡´É
- ´Ù¾çÇÑ Promoter, Reporter gene ±×¸®°í Antibiotic resistant gene ¼±Åð¡´É
- High-titer º¸Àå (1 x 10^8 ~ 10^9 IFU/ml)
- ÇØ¿Ü OEM »ý»êÀÌ ¾Æ´Ñ ±¹³» ·»Æ¼¹ÙÀÌ·¯½º »ý»ê½Ã½ºÅÛ: LMO ¼öÀԽŰí ÀýÂ÷°¡ ÇÊ¿ä¾øÀ½
- High stability lentivirus: ÀÚ»ç Á¦Ç°ÀÎ Lenti-Con¢â Reagent¿Í HIV-Safe¢â Manager¸¦ Á¦Ç° Á¦ÀÛ¿¡ È°¿ëÇÏ¿© Ÿ»çÁ¦Ç° ´ëºñ ³ôÀº ¾ÈÁ¤¼º º¸Àå
¼ºñ½º ÁøÇà °úÁ¤
°¡°Ý ¹× ¼Ò¿ä±â°£
Service Type | Titer[RT-qPCR] | Volume | Price (¿ø) | ¼Ò¿ä±â°£ |
---|---|---|---|---|
Pilot scale | > 1 x 10^8 IFU/ml | 0.25 ml | 400,000 | 2 ~ 3ÁÖ |
Medium scale | > 1 x 10^8 IFU/ml > 1 x 10^9 IFU/ml |
1.0 ml 0.1 ml |
1,000,000 | 2 ~ 3ÁÖ |
Large scale | > 1 x 10^8 IFU/ml > 1 x 10^9 IFU/ml |
10 ml 1.0 ml |
°ßÀû¹®ÀÇ | 2 ~ 3ÁÖ |
Vector cloning (< 2 kb) | Lentiviral vector ¹«»óÁ¦°ø | °ßÀû¹®ÀÇ | + 2ÁÖ |
* ¸ðµç ·»Æ¼¹ÙÀÌ·¯½º Á¦Ç°±º¿¡´Â °í°´ÀÇ Á¦Ç°»ç¿ë ÆíÀǸ¦ À§ÇØ transduction enhancerÀÎ Lenti-TD MAX°¡ ¹«»óÁ¦°ø µË´Ï´Ù.
* º¤ÅÍŬ·Î´×ºÎÅÍ ¹ÙÀÌ·¯½º Á¦ÀÛ±îÁö all-in-one ¼ºñ½º ÀÌ¿ë ½Ã ÃÖÁ¾ ¹ÙÀÌ·¯½º Á¦Ç° ¿Ü¿¡ Á¦ÀÛµÈ Lenti-viral transfer vector¿Í Àüü¼¿ÀÌ Æ÷ÇÔµÈ sequence map ÆÄÀÏÀÌ µ¿½Ã Á¦°øµË´Ï´Ù.
Lentivector Cloning ¼±ÅÃ¿É¼Ç (°ßÀû¿äû ½Ã ÇØ´ç»çÇ×À» ¿äûÇØ ÁÖ¼¼¿ä)
-
Two promoter system
* Promoter 1 : CMV, MSCV, EF1a, PGK Áß ¼±Åð¡´É
* Promoter 2 : EF1a, PGK Áß ¼±Åð¡´É (Promoter 1°ú 2¿¡ µ¿ÀÏÇÑ promoter ¼±ÅúҰ¡)
* Your Gene : Genebank Accession Number or cDNA sequence
* Reporter Gene : GFP, RFP, PuroR, BleoR, BSDR Áß ¼±Åð¡´É
-
One promter 2A system
* Promoter 1 : CMV, MSCV, EF1a, PGK Áß ¼±Åð¡´É
* Your Gene 1 & 2 : Genebank Accession Number or cDNA sequence
* Reporter Gene : GFP, RFP, PuroR, BleoR, BSDR Áß ¼±Åð¡´É
-
One promoter IRES system
* Promoter 1 : CMV, MSCV, EF1a, PGK Áß ¼±Åð¡´É
* Your Gene 1 & 2 : Genebank Accession Number or cDNA sequence
* Reporter Gene : GFP, RFP, PuroR, BleoR, BSDR Áß ¼±Åð¡´É
-
shRNA Expression system
* Promoter : U6 promoter ±âº» »ç¿ë
* Your shRNA : À¯Àú º¸À¯ shRNA ¼¿À̳ª ¼¿À» ¸ð¸¦ °æ¿ì Target GeneÀÇ Genebank Accession Number¸¦ Á¦°øÇϸé shRNA µðÀÚÀÎ °¡´É
* Reporter Gene : GFP, PuroR Áß ¼±Åð¡´É
-
gRNA Expression system (CRISPR/Cas9)
* Promoter : U6 promoter ±âº» »ç¿ë
* Your gRNA : À¯Àú º¸À¯ gRNA ¼¿À̳ª ¼¿À» ¸ð¸¦ °æ¿ì Target GeneÀÇ Genebank Accession Number¸¦ Á¦°øÇϸé gRNA µðÀÚÀÎ °¡´É
* Reporter Gene : PuroR ¸¸ °¡´É
-
miRNA Expression system
* Promoter : CMV promoter ±âº» »ç¿ë
* Your shRNA : miRNA À̸§À» ¾Ë·ÁÁֽøé pre-miRNA ¼¿ÀÌ Æ÷ÇÔµÈ 450 ~ 500 bp genomic sequence¸¦ ÇÕ¼ºÇÏ¿© Ŭ·Î´× ÇÔ.
* Reporter Gene : GFP, PuroR Áß ¼±Åð¡´É
-
TetO Inducible Expression system
* Promoter : TetO promoter ±âº» »ç¿ë
* Your Gene1 : Genebank Accession Number or cDNA sequence
* Your Gene2 : Another your 2nd gene or reporter gene (GFP, RFP, CFP, YFP Áß ÅÃ 1)
Promoter ¼±Åð¡À̵å
Promoter | Expression level | Application |
---|---|---|
CMV | High | In most cell lines |
MSCV | High | Hematopoietic and stem cells |
EF1a | Medium | Most cell types including primary cells and stem cells |
PGK | Medium | Most cell types including primary cells and stem cells |
U6 | High | shRNA specific expression |
Á¦Ç°ÀÇ QC
- ¹ÙÀÌ·¯½º ³óµµÃøÁ¤: RT-qPCR titration
¹ÙÀÌ·¯½º ¿ª°¡º¸Áõ ¿¹¿ÜÀÎ °æ¿ì
- ·»Æ¼¹ÙÀÌ·¯½º º¤ÅÍ·Î µµÀÔµÈ insert ±æÀÌ°¡ 4 kb ÀÌ»óÀÎ °æ¿ì
- Insert À¯ÀüÀÚ°¡ ¹ÙÀÌ·¯½º packaging¿¡ ¿µÇâÀ» ÁÖ´Â À¯ÀüÀÚÀÎ °æ¿ì
- ¹ÙÀÌ·¯½º packaging ¼¼Æ÷¿¡ insert À¯ÀüÀÚ°¡ µ¶¼ºÀ» À¯¹ßÇÏ´Â °æ¿ì
- Secondary structure À¯¹ß¼¿ ¹× ±× ¿Ü ¾Ë·ÁÁöÁö ¾ÊÀº ¸ÞÄ¿´ÏÁò¿¡ ÀÇÇØ ¹ÙÀÌ·¯½º packaging¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» À¯¹ßÇÏ´Â ¼¿ÀÎ °æ¿ì
- °í°´ Á¦°ø plasmid ³» ¹ÙÀÌ·¯½º packaging °ü·Ã ÁÖ¿äÀÎÀÚ°¡ °á¿©µÈ °æ¿ì
- °ËÁõµÈ envelop ÀÌ¿Ü¿¡ °í°´ Á¦°ø ´Ù¸¥ pseudo-envelop type ·»Æ¼¹ÙÀÌ·¯½º »ý»êÀ» ½ÃµµÇÏ´Â °æ¿ì